Ryan Casserly, MD
Otolaryngology/Facial Plastic Surgery · Monterey, CANPI 1114344025
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,300 of the $23,095 with a category attached, or 74.9%. Cochlear Americas accounts for 84.0% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $16,352, more than ten times the $83 reported in 2019. Among otolaryngology/facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $163.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$19K
- Sanofi$877
- GSK$449
- Med-el Corporation$447
- Advanced Bionics, LLC$426
- Pfizer$308
- plus $1K from 11 others
What the payments were for
- Consulting fees$17,30075%
- Travel & lodging$1,1285%
- Food & beverage$4,66020%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 15 | $19,392 |
| Sanofi | 28 | $877 |
| GSK | 19 | $449 |
| Med-el Corporation | 7 | $447 |
| Advanced Bionics, LLC | 10 | $426 |
| Pfizer | 13 | $308 |
| Stryker | 5 | $268 |
| AbbVie | 7 | $168 |
| Biohaven Pharmaceuticals, Inc. | 7 | $161 |
| Inspire Medical Systems, Inc. | 14 | $153 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $109 |
| Integra Lifesciences Corporation | 3 | $95 |
| Johnson & Johnson(2 entities) | 2 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Optinose US, Inc. | 2 | $47 |
| Intersect ENT, Inc. | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,095 in reported general payments places this provider in the 95th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 19 | $30,611 |
| Emgality PenGalcanezumab-Gnlm | 40 | $30,312 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $7,794 |
| Nortriptyline Hcl | 145 | $3,317 |
| Azelastine Hcl | 101 | $2,877 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 56 | $1,522 |
| Ipratropium Bromide | 60 | $1,514 |
| Fluticasone Propionate | 161 | $1,499 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,449 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 16 | $1,348 |
| Fludrocortisone Acetate | 29 | $713 |
| Pantoprazole Sodium | 64 | $643 |
| Mometasone Furoate | 53 | $592 |
| Cartia XtDiltiazem Hcl | 23 | $467 |
| Divalproex Sodium ErDivalproex Sodium | 14 | $440 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $168 | $30,61119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 102 otolaryngology/facial plastic surgery providers in California.
Other otolaryngology/facial plastic surgery in Monterey
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Jahangir SharifiLos Angeles$12K
- Henry NguyenRancho Cucamonga$11K
- Paul NassifBeverly Hills$10K
- Babak AzizzadehBeverly Hills$10K
- Arash MoradzadehBeverly Hills$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.